Companies Dominating the Perineural Therapy Landscape
- Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- tVNS Technologies GmbH
- Abbott Laboratories
- NeuroSigma, Inc.
- Axogen Corporation
- BioWave Limited
- Baxter Healthcare Corporation
- LivaNova, PLC
- Integra LifeSciences Corporation
- Soterix Medical, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of perineural therapy is assessed at USD 502.87 million.
The perineural therapy market size was valued at USD 399.17 million in 2024 and is expected to reach USD 2.54 billion by 2037, registering around 15.3% CAGR during the forecast period i.e., between 2025-2037. The higher prevalence of different sorts of neural disorders and the increment in approval of more enhanced products to repair and regenerate nerves will boost the market growth.
North America industry is likely to account for largest revenue share by 2037, on the back of a higher prevalence of sports injuries.
The major players in the market are Boston Scientific Corporation, tVNS Technologies GmbH, Abbott Laboratories, NeuroSigma, Inc., Axogen Corporation, BioWave Limited, Baxter Healthcare Corporation, LivaNova, PLC, Integra LifeSciences Corporation, Soterix Medical, Inc.
